プレフィルドシリンジの市場規模、シェア、成長分析、タイプ別、デザイン別、材料別、用途別、地域別 - 産業予測、2024年～2031年

世界のプレフィルドシリンジの市場規模は、2022年に68億米ドルとなり、2023年の75億2,000万米ドルから、2031年までには168億4,000万米ドルに成長し、予測期間（2024年～2031年）のCAGRは10.60％で成長する見通しです。

プレフィルドシリンジ市場の成長は、主に効率的でユーザーフレンドリーなドラッグデリバリーシステムに対する需要の増加と、病院でのミスを減らすためのヘルスケア専門家の努力によってもたらされます。この市場拡大の要因としては、在宅医療サービスの増加、注射薬の使用の増加、慢性疾患の有病率の増加、従来のバイアルと比較したプレフィルドシリンジの利点などが挙げられます。また、プレフィルドシリンジの技術的進歩も市場の成長を支える重要な役割を果たしています。しかし、代替医療提供方法の利用可能性、厳しい政府規制、製品リコールなどの課題に直面しており、市場拡大の妨げとなる可能性があります。逆に、生物製剤やバイオシミラーの開発、プレフィルドタイプの注射薬に対する需要の高まりは、業界の将来的な成長に有望な機会を提供しています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次・一次情報源
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 市場概要展望
• 供給需要動向分析
• セグメント別機会分析

市場力学と展望

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主要な市場の考察

• 技術分析
• 価格分析
• バリューチェーン分析
• 市場のエコシステム
• 貿易分析
• サプライチェーン分析
• ケーススタディ分析
• 特許分析
• 顧客と購買基準の分析
• 規制情勢
• イノベーションマトリクス
• 主要な投資分析
• 主要な成功要因
• 競合の程度

プレフィルドシリンジ市場：タイプ別

• 市場概要
• 従来のプレフィルドシリンジ
  • 使い捨てプレフィルドシリンジ
  • 再利用可能プレフィルドシリンジ
• 安全性プレフィルドシリンジ

プレフィルドシリンジ市場：設計別

• 市場概要
• シングルチャンバープレフィルドシリンジ
• デュアルチャンバープレフィルドシリンジ
• カスタマイズされたプレフィルドシリンジ

プレフィルドシリンジ市場：材料別

• 市場概要
• ガラスプレフィルドシリンジ
• プラスチックプレフィルドシリンジ

プレフィルドシリンジ市場：用途別

• 市場概要
• 糖尿病
• 関節リウマチ
• アナフィラキシー
• がん
• 血栓症
• 眼科
• その他

プレフィルドシリンジ市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主要な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• BD（US）
• Gerresheimer AG（Germany）
• SCHOTT（Germany）
• West Pharmaceutical Services, Inc.（US）
• AptarGroup, Inc.（US）
• Nipro（Japan）
• Baxter（Simtra）（US）
• Owen Mumford Ltd.（UK）
• Weigao Medical International Co., Ltd.（China）
• Credence MedSystems, Inc.（US）
• Novartis AG（Switzerland）
• Stevanato Group（Italy）
• Poly Medicure（India）
• MedXL Inc.（Canada）
• Sharps Technology, Inc.（US）
• Fresenius Kabi USA（US）
• Medefil, Inc.（US）
• D.B.M. S.R.L.（Italy）
• Taisei Kako Co., Ltd.（Japan）
• Shandong Province Medicinal Glass Co., Ltd.（China）
• Shin Yan Sheno Precision Industrial Co., Ltd.（Taiwan）
• J.O. Pharma Co., Ltd.（Otsuka Holdings Co., Ltd.）（Japan）
• BMI Korea（South Korea）
• Al Shifa Medical Products Co.（Saudi Arabia）

Global Prefilled Syringes Market size was valued at USD 6.8 billion in 2022 and is poised to grow from USD 7.52 billion in 2023 to USD 16.84 billion by 2031, growing at a CAGR of 10.60% during the forecast period (2024-2031).

The growth of the prefilled syringes market is primarily driven by increasing demand for efficient and user-friendly drug delivery systems, coupled with efforts by healthcare professionals to reduce hospital errors. Factors contributing to this market expansion include the rise in home healthcare services, the growing use of injectable medications, the higher prevalence of chronic diseases, and the benefits of prefilled syringes compared to traditional vials. Technological advancements in prefilled syringes also play a crucial role in supporting market growth. However, the market faces challenges such as the availability of alternative medicine delivery methods, stringent government regulations, and product recalls, which may hinder its expansion. Conversely, the development of biologics and biosimilars, along with the increasing demand for injectable medications in prefilled formats, offer promising opportunities for future growth in the industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Prefilled Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Prefilled Syringes Market Segmental Analysis

Global Prefilled Syringes Market is segmented by Type, Design, Material, Application, and region. Based on Type, the market is segmented into Conventional Prefilled Syringes, and Safety Prefilled Syringes. Based on Design, the market is segmented into Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes. Based on Material, the market is segmented into Glass Prefilled Syringes, and Plastic Prefilled Syringes. Based on Application, the market is segmented into Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Prefilled Syringes Market

Prefilled syringes are commonly utilized for managing chronic conditions, enabling patients to self-administer their medications for diseases such as diabetes, heart disorders, and autoimmune conditions. The growing global prevalence of these chronic and life-threatening diseases is driving an expansion in the prefilled syringes market. Additionally, the increasing demand for self-injection devices is fueled by their convenience and safety, further contributing to the market's growth.

Restraints in the Global Prefilled Syringes Market

Global growth in the prefilled syringes market faces significant challenges, including product recalls, potential reactions between drugs and syringe components, and other related issues. A notable example occurred, when Novartis Pharmaceuticals UK recalled a batch of Lucentis 10 mg/ml injection solution due to a defect in the plunger stopper. This recall resulted in an uptick in customer complaints regarding difficulties in operating the plunger.

Market Trends of the Global Prefilled Syringes Market

Biologics and biosimilars are increasingly taking the place of chemical-based drugs in the global life science market. These biologics are favored for their targeted delivery capabilities and lower risk of drug interactions, leading to a growing preference for their use. Consequently, pharmaceutical and packaging manufacturers face pressure to innovate and develop advanced container closure and drug delivery systems. This shift has significantly boosted the adoption of prefilled syringes designed for the safe administration of biologics and biosimilars. For example, the Central Drugs Standard Control Organization (CDSCO) in India has approved 98 biosimilars to date, reflecting the expanding use and acceptance of these advanced treatments.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Value Chain Analysis
• Ecosystem of the Market
• Trade Analysis
• Supply chain Analysis
• Case study Analysis
• Patent Analysis
• Customer & Buying Criteria Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Prefilled Syringes Market by Type

• Market Overview
• Conventional Prefilled Syringes
  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes
• Safety Prefilled Syringes

Prefilled Syringes Market by Design

• Market Overview
• Single-chamber Prefilled Syringes
• Dual-chamber Prefilled Syringes
• Customized Prefilled Syringes

Prefilled Syringes Market by Material

• Market Overview
• Glass Prefilled Syringes
• Plastic Prefilled Syringes

Prefilled Syringes Market by Application

• Market Overview
• Diabetes
• Rheumatoid Arthritis
• Anaphylaxis
• Cancer
• Thrombosis
• Ophthalmology
• Others

Prefilled Syringes Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• BD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gerresheimer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SCHOTT (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter (Simtra) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Owen Mumford Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weigao Medical International Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Credence MedSystems, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stevanato Group (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Poly Medicure (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedXL Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharps Technology, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi USA (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medefil, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• D.B.M. S.R.L. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taisei Kako Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shandong Province Medicinal Glass Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shin Yan Sheno Precision Industrial Co., Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.O. Pharma Co., Ltd. (Otsuka Holdings Co., Ltd.) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BMI Korea (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Al Shifa Medical Products Co. (Saudi Arabia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments